Showing results (31-40 of 46) with videos related to
Sort By:
Pageof 5
The Journal of Rheumatology|October 9, 2007
Improvement and longterm maintenance of quality of life during treatment with adalimumab in severe rheumatoid arthritisThomas Mittendorf, Birgitta Dietz, Raimund Sterz, et al.Pflege Zeitschrift|June 5, 2010
[Aspects of outpatient palliative care and assessment of the nursing workload. Survey among care givers in Germany]Anne Prenzler, Christof H Müller-Busch, Thomas Mittendorf, et al.Annals of the Rheumatic Diseases|January 11, 2014
Evolution of cost structures in rheumatoid arthritis over the past decadeDörte Huscher, Thomas Mittendorf, Ulrich von Hinüber, et al.Rheumatology (Oxford, England)|December 15, 2010
Cost of illness in rheumatoid arthritis in Germany in 1997-98 and 2002: cost drivers and cost savingsTimm Kirchhoff, Jörg Ruof, Thomas Mittendorf, et al.Clinical Therapeutics|June 4, 2011
Cost-effectiveness of targeted therapy with cetuximab in patients with K-ras wild-type colorectal cancer presenting with initially unresectable metastases limited to the liver in a German settingChristian Asseburg, Martin Frank, Claus-Henning Köhne, et al.The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 29, 2004
Comparison of estimated medical costs among patients who are defined as having rheumatoid arthritis using three different standardsJörg Ruof, Jan L Hülsemann, Thomas Mittendorf, et al.GMS Health Technology Assessment|February 4, 2011
Assessment of effectiveness and cost-effectiveness of HPV testing in primary screening for cervicalThomas Mittendorf, Marc Nocon, Stephanie Roll, et al.Arthritis and Rheumatism|October 13, 2004
Patient-reported health care utilization in rheumatoid arthritis: what level of detail is required?Jörg Ruof, Jan L Huelsemann, Thomas Mittendorf, et al.BMC Neurology|August 27, 2009
Quality of life as an outcome in Alzheimer's disease and other dementias--obstacles and goalsMatthias W Riepe, Thomas Mittendorf, Hans Förstl, et al.Health Economics Review|December 14, 2020
Application study of the EQ-5D-5L in oncology: linking self-reported quality of life of patients with advanced or metastatic colorectal cancer to clinical data from a German tumor registryKathrin Borchert, Christian Jacob, Natalie Wetzel, et al.Pageof 5